Literature DB >> 16198562

Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors.

Xiaohu Ouyang1, Xiaoling Chen, Evgueni L Piatnitski, Alexander S Kiselyov, Hai-Ying He, Yunyu Mao, Vatee Pattaropong, Yang Yu, Ki H Kim, John Kincaid, Leon Smith, Wai C Wong, Sui Ping Lee, Daniel L Milligan, Asra Malikzay, James Fleming, Jason Gerlak, Dhanvanthri Deevi, Jacqueline F Doody, Hui-Hsien Chiang, Sheetal N Patel, Ying Wang, Robin L Rolser, Paul Kussie, Marc Labelle, M Carolina Tuma.   

Abstract

A novel triazole-containing chemical series was shown to inhibit tubulin polymerization and cause cell cycle arrest in A431 cancer cells with EC(50) values in the single digit nanomolar range. Binding experiments demonstrated that representative active compounds of this class compete with colchicine for its binding site on tubulin. The syntheses and structure-activity relationship studies for the triazole derivatives are described herein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198562     DOI: 10.1016/j.bmcl.2005.08.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Filippo Prencipe; Valerio Bertolasi; Michela Cancellieri; Andrea Brancale; Ernest Hamel; Ignazio Castagliuolo; Francesca Consolaro; Elena Porcù; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2014-07-28       Impact factor: 7.446

2.  Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy.

Authors:  Eugene L Piatnitski Chekler; Alexander S Kiselyov; Xiaohu Ouyang; Xiaoling Chen; Vatee Pattaropong; Ying Wang; M Carolina Tuma; Jacqueline F Doody
Journal:  ACS Med Chem Lett       Date:  2010-08-20       Impact factor: 4.345

3.  Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor.

Authors:  Maria Carolina Tuma; Asra Malikzay; Xiaohu Ouyang; David Surguladze; James Fleming; Stan Mitelman; Margarita Camara; Bridget Finnerty; Jacqueline Doody; Eugene L P Chekler; Paul Kussie; James R Tonra
Journal:  Transl Oncol       Date:  2010-10-01       Impact factor: 4.243

4.  Novel ferrocenyl derivatives exert anti-cancer effect in human lung cancer cells in vitro via inducing G1-phase arrest and senescence.

Authors:  Ying Li; Han-lin Ma; Lei Han; Wei-yong Liu; Bao-xiang Zhao; Shang-li Zhang; Jun-ying Miao
Journal:  Acta Pharmacol Sin       Date:  2013-05-06       Impact factor: 6.150

5.  3-{[5-(4-Chloro-phen-yl)-3-methyl-1H-pyrazol-1-yl]meth-yl}-4-m-tolyl-1H-1,2,4-triazole-5(4H)-thione.

Authors:  Muhammad A Farrukh; Maqsood Ahmed; Shaaban K Mohamed; Adel A Marzouk; Samir M El-Moghazy
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-05-22

6.  4-(5-Amino-1H-1,2,4-triazol-3-yl)pyridinium chloride monohydrate.

Authors:  Victor M Chernyshev; Elena V Tarasova; Anna V Chernysheva; Victor B Rybakov
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-22

7.  Novel Water Soluble Chitosan Derivatives with 1,2,3-Triazolium and Their Free Radical-Scavenging Activity.

Authors:  Qing Li; Xueqi Sun; Guodong Gu; Zhanyong Guo
Journal:  Mar Drugs       Date:  2018-03-28       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.